Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between proteomic biomarkers and myocardial fibrosis measured by MRI: the multi-ethnic study of atherosclerosis
Hooman Bakhshi, Sam A. Michelhaugh, Scott A. Bruce, et al.
EBioMedicine (2023) Vol. 90, pp. 104490-104490
Open Access | Times Cited: 19

Showing 19 citing articles:

Hegemony of inflammation in atherosclerosis and coronary artery disease
Ali Attiq, Sheryar Afzal, Waqas Ahmad, et al.
European Journal of Pharmacology (2024) Vol. 966, pp. 176338-176338
Open Access | Times Cited: 58
MicroRNA-19a-3p inhibits endothelial dysfunction in atherosclerosis by targeting JCAD
Jinque Luo, Lingling Wang, Chaoyue Cui, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Associations of Circulating Vascular Cell Adhesion Molecule‐1 and Intercellular Adhesion Molecule‐1 With Long‐Term Cardiac Function
Daniel T. Mathew, Graham Peigh, João A.C. Lima, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 6
Open Access | Times Cited: 7
Machine Learning Identifies Key Proteins in Primary Sclerosing Cholangitis Progression and Links High CCL24 to Cirrhosis
Tom Snir, Raanan Greenman, Revital Aricha, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6042-6042
Open Access | Times Cited: 4
Innovative Approaches in Atherosclerosis Treatment: Harnessing Traditional Chinese Medicine to Target Long Non-Coding RNAs
Xiaofang Chen, Wen‐yan Ding, Yifan Liu, et al.
Phytomedicine (2025) Vol. 139, pp. 156488-156488
Closed Access
New insights into Smad3 in cardiac fibrosis
Zhen Gao
Gene (2025) Vol. 952, pp. 149418-149418
Closed Access
Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart Failure
Rachad Ghazal, Min Wang, Duan Liu, et al.
Circulation Research (2025) Vol. 136, Iss. 7, pp. 773-802
Closed Access
Multi‐omic analyses and network biology in cardiovascular disease
Cristine J. Reitz, Uroš Kuzmanov, Anthony O. Gramolini
PROTEOMICS (2023) Vol. 23, Iss. 21-22
Open Access | Times Cited: 10
TUDCA alleviates atherosclerosis by inhibiting AIM2 inflammasome and enhancing cholesterol efflux capacity in macrophage
Xuyang Wang, Yuesheng Zhang, Luping Du, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109849-109849
Open Access | Times Cited: 3
Proteomic mapping identifies serum marker signatures associated with MIS-C specific hyperinflammation and cardiovascular manifestation
Andrea Reiter, Emely Verweyen, Emmanuelle Queste, et al.
Clinical Immunology (2024) Vol. 264, pp. 110237-110237
Open Access | Times Cited: 3
m6A epitranscriptomic modification of inflammation in cardiovascular disease
Yun-Sen Zhang, Zhiyan Liu, Zhenyu Liu, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112222-112222
Closed Access | Times Cited: 1
PGC1α enhances macrophage efferocytosis in ox-LDL-stimulated RAW264.7 cells by regulating the NLRP3/PPARα axis
Qi Long Lu, Xujiao Chen, Qijun Zhang
Tissue and Cell (2024) Vol. 90, pp. 102476-102476
Closed Access
Inhibition of CTLA-4 accelerates atherosclerosis in hyperlipidemic mice by modulating the Th1/Th2 balance via the NF-κB signaling pathway
M. Zhao, Liang Chen, Weiwei Jiang, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37278-e37278
Open Access
Possible mechanisms of SARS-CoV-2-associated myocardial fibrosis: reflections in the post-pandemic era
Zhan Wang, Luwei Li, Shuai Yang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
Dietary patterns and premature coronary artery disease: result from the Iran premature coronary artery disease (IPAD) study
Ghazal Ghasempour Dabaghi, Ehsan Zarepur, Mehrdad Rabiee Rad, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access
Diosgenin: A Potential Therapeutic Phytocompound for the Management of Atherosclerosis and Other Physiological Disorders
Rizwan‐ur Rehman, Sania Riaz, Misha Arooj, et al.
Natural Product Communications (2024) Vol. 19, Iss. 12
Open Access
Circulating microRNA as promising biomarkers in hypertrophic cardiomyopathy: can advanced cardiac magnetic resonance unlock new insights in research?
О. С. Чумакова, Е. А. Мершина
Experimental Biology and Medicine (2024) Vol. 249
Open Access
The liver-heart axis in patients with severe obesity: The association between liver fibrosis and chronic myocardial injury may be explained by shared risk factors of cardiovascular disease
James B. Young, Kathrine Aglen Seeberg, Kristin M. Aakre, et al.
Clinical Biochemistry (2023) Vol. 123, pp. 110688-110688
Open Access | Times Cited: 1
Omaveloxolone ameliorates isoproterenol-induced pathological cardiac hypertrophy in mice
Xianchao Li, Yang Wu, Yunzhao Yang, et al.
Free Radical Research (2023) Vol. 58, Iss. 1, pp. 57-68
Closed Access | Times Cited: 1
Page 1

Scroll to top